Related Experiment Video
Updated: Nov 10, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Rethinking heart failure care and health technologies from early COVID-19 experiences - A narrative review
Sakine Satici1, Pupalan Iyngkaran2, Sharon Andrew1
1Victoria University, PO Box 14428 Melbourne Victoria 8001, Melbourne, Australia.
Insights
The COVID-19 pandemic challenged heart failure (HF) management, highlighting gaps in care for vulnerable populations. Health technology offers promising solutions to improve HF service delivery and address these challenges.
Area of Science:
- Cardiology
- Health Services Research
- Digital Health
Background:
- Heart Failure (HF) management necessitates multidisciplinary care, but the COVID-19 pandemic disrupted traditional healthcare models.
- Existing evidence-based guidelines for HF treatment face challenges in translation to real-world practice, especially for vulnerable patient groups.
- Service improvement studies have bridged some gaps, yet disparities persist for severe HF, comorbidities, and remote populations.
Purpose of the Study:
- To review recent advancements in health technology aimed at addressing service gaps in heart failure care.
- To examine the impact of the COVID-19 pandemic on Australian heart failure management outside conventional care models.
- To explore how health technology can mitigate challenges in chronic disease management.
Main Methods:
- This narrative review synthesizes information on health technology's role in heart failure management.
- It examines observations from the Australian healthcare system during the COVID-19 pandemic.
- The review focuses on recent developments and their potential to improve service delivery.
Main Results:
- The pandemic accelerated the adoption of non-traditional care models for heart failure.
- Health technology has emerged as a key enabler for overcoming service delivery gaps.
- Specific technologies show promise in enhancing management for underserved HF populations.
Conclusions:
- Health technology presents a significant opportunity to enhance heart failure care delivery, particularly for vulnerable groups.
- The post-pandemic era requires innovative solutions to ensure equitable access to optimal heart failure management.
- Continued evaluation of health technology is crucial for refining service models and improving patient outcomes.
Abstract:
Heart Failure (HF), a common chronic disease, requires multidisciplinary care to optimise outcomes. The COVID-19 pandemic, its impact on people's movement and access to health services, introduced severe challenges to chronic disease management. The era that will evolve after this pandemic is likely to provide uncertainty and service model disruptions. HF treatment is based on guidelines derived from randomised clinical trial evidence. Translational shortfalls from trials into practice have been overcome with post-trial service improvement studies like OPTIMIZE-HF where a team using a process of care can translate evidence to the general population. However, gaps remain for vulnerable populations e.g. those with more severe HF, with multiple comorbid conditions, and certain demographic groups and/or residents in remote locations. Health technology has come with great promise, to fill some of these gaps. The COVID-19 pandemic provides an opportunity to observe, from Australian healthcare lens, HF management outside the traditional model of care. This narrative review describes relatively recent events with health technology as a solution to improve on service gaps.
More Related Videos
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Rheumatic Heart Disease III: Medical Management